- 期刊
Amyloid Beta and Tau Proteins as Therapeutic Targets for Alzheimer's Disease Treatment: Rethinking the Current Strategy
被引用紀錄
Hao, C. C. (2016). 肌萎縮性脊髓側索硬化症相關之TDP-43突變蛋白質的結構與生化特性分析 [doctoral dissertation, National Tsing Hua University]. Airiti Library. https://www.airitilibrary.com/Article/Detail?DocID=U0016-2309201616094347
延伸閱讀
- Gough, M., Sturgess, C. P., & Parkin, E. (2011). Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer’s Disease. Biochemistry Research International, 2011(), 230-242. https://doi.org/10.1155/2011/721463
- Kolarova, M., Sierra, F. G., Bartos, A., Ricny, J., & Ripova, D. (2012). Structure and Pathology of Tau Protein in Alzheimer Disease. International Journal of Alzheimer＇s Disease, 2012(), 782-794. https://doi.org/10.1155/2012/731526
- Morelli, L., Perry, G., & Tagliavini, F. (2012). The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview. International Journal of Alzheimer＇s Disease, 2012(), 756-757. https://doi.org/10.1155/2012/709613
- Nizzari, M., Thellung, S., Corsaro, A., Villa, V., Pagano, A., Porcile, C., Russo, C., & Florio, T. (2012). Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin1 Intracellular Signaling. Journal of Toxicology, 2012(), 92-104. https://doi.org/10.1155/2012/187297
- Chen, R. S. (2019). Understanding the Molecular Interaction of TDP-43 and Amyloid-β in Alzheimer’s disease [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU201903526